Products Categories
CAS No.: | 138-14-7 |
---|---|
Name: | Deferoxamine mesylate |
Article Data: | 1 |
Molecular Structure: | |
Formula: | C25H48N6O8.CH4O3S |
Molecular Weight: | 656.798 |
Synonyms: | Deferoxamine mesilate (JP14);Desferal;Prestwick_988;Deferoxamine mesylate (USP);Butanediamide,N'-[5-[[4-[[5-(acetylhydroxyamino) pentyl]amino]-1,4-dioxobutyl]hydroxyamino] pentyl]-N-(5-aminopentyl)-Nhydroxy-,monomethanesulfonate (salt);Desferal (TN); |
EINECS: | 205-314-3 |
Melting Point: | 148-149° |
Boiling Point: | 966.9 °C at 760 mmHg |
Flash Point: | 538.5 °C |
Appearance: | white to off-white powder |
Safety: | 22-24/25 |
PSA: | 268.59000 |
LogP: | 2.98900 |
Conditions | Yield |
---|---|
With sodium carbonate In water at 24℃; for 0.25h; pH=7 - 7.5; | 100% |
succinic acid anhydride
deferoxamine mesylate
N-Succinyl-desferri-ferrioxyamin B
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 20℃; for 42h; Inert atmosphere; | 97% |
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 50℃; Solvent; Temperature; Inert atmosphere; | |
With pyridine at 20℃; Inert atmosphere; | 0.232 g |
2-benzyloxybenzoyl chloride
deferoxamine mesylate
N,O',O'',O'''-Tetra(2-benzyloxy-benzoyl)desferri-ferrioxamin B
Conditions | Yield |
---|---|
With sodium hydrogencarbonate In diethyl ether; water for 1h; | 93% |
Conditions | Yield |
---|---|
With sodium hydroxide In methanol at 40℃; for 4h; Product distribution / selectivity; | 92% |
Conditions | Yield |
---|---|
Stage #1: deferoxamine mesylate With sodium hydroxide In methanol Stage #2: 1-(N-succinimidyloxycarbonyl)adamantane In methanol at 55℃; for 4h; Product distribution / selectivity; | 92% |
1 ,4-phenylenediisothiocyanate
deferoxamine mesylate
N-[5-({3-[5-(acetyl-hydroxy-amino)-pentylcarbamoyl]-propionyl}-hydroxy-amino)-pentyl]-N'-hydroxy-N'-{5-[3-(4-isothiocyanato-phenyl)-thioureido]-pentyl}-succinamide
Conditions | Yield |
---|---|
With triethylamine In chloroform; water; isopropyl alcohol | 85% |
di-tert-butyl dicarbonate
deferoxamine mesylate
1-(tert-Butoxycarbonyl)-7,18,29-trihydroxy-8,11,19,22,30-pentaoxo-1,7,12,18,23,29-hexaazahentriacontane
Conditions | Yield |
---|---|
With triethylamine In 1,4-dioxane; water at 40℃; for 16h; | 83% |
With sodium carbonate In 1,4-dioxane; water |
Conditions | Yield |
---|---|
Stage #1: deferoxamine mesylate With N-ethyl-N,N-diisopropylamine In ethanol at 50℃; for 1h; Stage #2: 3,4-diethoxy-3-cyclobuten-1,2-dione In ethanol at 50℃; for 0.5h; | 83% |
Stage #1: deferoxamine mesylate With N-ethyl-N,N-diisopropylamine In ethanol at 50℃; for 1h; Stage #2: 3,4-diethoxy-3-cyclobuten-1,2-dione In ethanol at 50℃; for 0.5h; | 83% |
Conditions | Yield |
---|---|
With N-ethyl-N,N-diisopropylamine In dimethyl sulfoxide for 4h; | 82% |
3,5-dimethyl-1-adamantanecarboxylic acid
deferoxamine mesylate
DFOB-AdAdMe
Conditions | Yield |
---|---|
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere; | 80% |
What can I do for you?
Get Best Price
Molecular Structure of Deferoxamine mesylate (CAS NO.138-14-7):
IUPAC Name: N-[5-[[4-[5-[Acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide ; Methanesulfonic acid
Molecular Weight: 656.78968 [g/mol]
Molecular Formula: C26H52N6O11S
H-Bond Donor: 7
H-Bond Acceptor: 12
EINECS: 205-314-3
Storage temp.: −20 °C
Solubility: H2O: 50 mg/mL
Appearance: white to off-white powder
Flash Point: 538.5 °C
Enthalpy of Vaporization: 152.67 kJ/mol
Boiling Point: 966.9 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25 °C
Classification Code: Antidote [to iron poisoning]; Chelating agent; Drug / Therapeutic Agent; Human Data
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | parenteral | 16gm/kg/34W-I (16000mg/kg) | CARDIAC: PERICARDITIS GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE BLOOD: OTHER CHANGES | American Journal of Kidney Diseases. Vol. 10, Pg. 71, 1987. |
man | TDLo | subcutaneous | 143mg/kg/4D-I (143mg/kg) | SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING | British Medical Journal. Vol. 291, Pg. 448, 1985. |
mouse | LD50 | intraperitoneal | 1240mg/kg (1240mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 1181, 1973. |
mouse | LD50 | intravenous | 273mg/kg (273mg/kg) | Drugs in Japan Vol. 6, Pg. 496, 1982. | |
mouse | LD50 | oral | 15200mg/kg (15200mg/kg) | Drugs in Japan Vol. 6, Pg. 496, 1982. | |
mouse | LD50 | subcutaneous | 1280mg/kg (1280mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 1181, 1973. |
rat | LD50 | intravenous | 330mg/kg (330mg/kg) | Drugs in Japan Vol. 6, Pg. 496, 1982. | |
rat | LD50 | oral | 17300mg/kg (17300mg/kg) | Drugs in Japan Vol. 6, Pg. 496, 1982. | |
rat | LD50 | subcutaneous | 5500mg/kg (5500mg/kg) | Drugs in Japan Vol. 6, Pg. 496, 1982. | |
women | TDLo | subcutaneous | 150mg/kg/4D-I (150mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING | British Medical Journal. Vol. 291, Pg. 448, 1985. |
women | TDLo | unreported | 900mg/kg/30W- (900mg/kg) | BRAIN AND COVERINGS: OTHER DEGENERATIVE CHANGES CARDIAC: CARDIOMYOPATHY INCLUDING INFARCTION LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA | American Journal of Medicine. Vol. 87, Pg. 468, 1989. |
Safety Information of Deferoxamine mesylate (CAS NO.138-14-7):
Safety Statements: 22-24/25
S22:Do not breathe dust.
S24/25:Avoid contact with skin and eyes.
WGK Germany: 2
RTECS: UG5310000
Poison by intravenous route. Moderately toxic by subcutaneous and intraperitoneal routes. Mildly toxic by ingestion. Human systemic effects: acute pulmonary edema, blood changes, cardiomyopathy, degenerative brain changes, diarrhea, hypermotility, nausea or vomiting, pericarditis, ulceration or bleeding from small intestine, visual field changes. When heated to decomposition it emits toxic fumes of NOx and SOx.
Deferoxamine mesylate (CAS NO.138-14-7), its Synonyms are Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate ; Desferal methanesulfonate ; Desferrioxamine B mesylate ; Desferrioxamine B methanesulfonate ; Desferrioxamine mesylate ; Desferrioxamine methanesulfonate ; N-(5-(3-((5-Aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)propionohydroxamic acid monomethanesulfonate (salt) .